Can Signal Enhancement Ratio (SER) Reduce the Number of Recommended Biopsies without Affecting Cancer Yield in Occult MRI-detected Lesions?

Academic Radiology

Volumn 18, Issue 6, 2011, Pages 716-721

  Arasu, Vignesh A ^a   Chen, Ryan C Y ^a   Newitt, David N ^a   Chang, C Belinda ^a   Tso, Hilda ^a   Hylton, Nola M ^a   Joe, Bonnie N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR VOLUME;

BIOPSY; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 79955613999     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2011.02.008     Document Type: Article

References (25)

1. Kuhl C.K. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007, 244:672-691.
2. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
3. Bassett L.W., Dhaliwal S.G., Eradat J., et al. National trends and practices in breast MRI. AJR Am J Roentgenol 2008, 191:332-339.
4. Houssami N., Hayes D. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA: Cancer J Clin 2009, 59:290-302.
5. Kuhl C., Kuhn W., Braun M., et al. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?. Breast 2007, 16(Suppl 2):S34-S44.
6. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006, 24:3293-3298.
7. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magnet Res Imaging JMRI 1997, 7:91-101.
8. Li K.L., Henry R.G., Wilmes L.J., et al. Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging. Magnet Res Med 2007, 58:572-581.
9. Esserman L., Hylton N., George T., et al. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999, 5:13-21.
10. Hylton N.M. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 1999, 7:411-420. x.
11. Lehman C.D., Peacock S., DeMartini W.B., et al. A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity. AJR Am J Roentgenol 2006, 187:51-56.
12. Wang L.C., DeMartini W.B., Partridge S.C., et al. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol 2009, 193:826-831.
13. Eby P.R., Partridge S.C., White S.W., et al. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Acad Radiol 2008, 15:1246-1254.
14. Karahaliou A., Vassiou K., Arikidis N.S., et al. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. Br J Radiol 2010, 83:296-309.
15. D'Orsi C.J., Bassett L.W., Berg W.A., et al. Breast Imaging Reporting and Data System: ACR BI-RADS-Mammography 2003, American College of Radiology, Reston, VA. 4th ed.
16. ACRIN. Protocol 6657. In: American College of Radiology Imaging Network (ACRIN). Available online at: http://www.acrin.org/6657_protocol.aspx.
17. Moon M., Cornfeld D., Weinreb J. Dynamic contrast-enhanced breast MR imaging. Magn Reson Imaging Clin N Am 2009, 17:351-362.
18. Szabo B.K., Aspelin P., Wiberg M.K., et al. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 2003, 44:379-386.
19. Williams T.C., DeMartini W.B., Partridge S.C., et al. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Radiology 2007, 244:94-103.
20. Baltzer P.A., Renz D.M., Kullnig P.E., et al. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis?. Acad Radiol 2009, 16:435-442.
21. Levman J.E., Causer P., Warner E., et al. Effect of the enhancement threshold on the computer-aided detection of breast cancer using MRI. Acad Radiol 2009, 16:1064-1069.
22. Paldino M.J., Barboriak D.P. Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am 2009, 17:277-289.
23. Kelcz F., Furman-Haran E., Grobgeld D., et al. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol 2002, 179:1485-1492.
24. Hauth E.A., Stockamp C., Maderwald S., et al. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography. Clin Imaging 2006, 30:160-165.
25. Jansen S.A., Shimauchi A., Zak L., et al. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol 2009, 193:832-839.